These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6345366)

  • 1. Reduced ratio of active-to-total urinary kallikrein in essential hypertension.
    Lieberthal W; Arbeit L; Oza NB; Bernard DB; Levinsky NG
    Hypertension; 1983; 5(4):603-9. PubMed ID: 6345366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary kallikrein excretion in young borderline hypertensive patients.
    Ando K; Fujita T
    Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels.
    Koolen MI; Daha MR; Frölich M; Van Es LA; Van Brummelen P
    Eur J Clin Invest; 1984 Jun; 14(3):171-4. PubMed ID: 6432545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of urinary kallikrein and plasma renin activities does not affect established hypertension in the fawn-hooded rat.
    Gilboa N; Rudofsky UH; Phillips MI; Magro AM
    Nephron; 1989; 51(1):61-6. PubMed ID: 2644567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB; Chud JM; Braunstein H
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations between circulation levels of natriuretic atrial peptide and urinary excretion of kallikrein in young normotensive and hypertensive subjects].
    Ferri C; Cammarella I; Giarrizzo C; Bellini C; Astorre P; Di Zenzo P; Santucci A; Musca A; Balsano F
    Ann Ital Med Int; 1991; 6(2):217-23. PubMed ID: 1836137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
    Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
    Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein activity is not altered in human essential hypertension.
    Simonetti BM; Pierucci A; Taggi F; Morabito S; Vastano S; Marchetti S; Putini RL; Stirati G; Cinotti GA
    Uremia Invest; 1985-1986; 9(2):189-93. PubMed ID: 3915922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of two different assays for urinary kallikrein in normotensive and hypertensive subjects.
    Maier M; Jerabek I; Reissert G; Höltzl E; Binder BR
    Clin Chim Acta; 1988 Dec; 178(2):127-39. PubMed ID: 3242981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension.
    Ura N; Shimamoto K; Nakao T; Ogasawara A; Tanaka S; Mita T; Nishimiya T; Iimura O
    Clin Exp Hypertens A; 1983; 5(3):329-37. PubMed ID: 6188559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal kallikrein activity in spontaneously hypertensive rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Omata K; Kasai Y; Sato M; Takeuchi K; Itoh S; Kanazawa M
    J Hypertens; 1987 Dec; 5(6):687-92. PubMed ID: 2448368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
    Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
    Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of urinary kallikrein acitvity by kinin radioimmunoassay.
    Shimamoto K; Tanaka S; Nakao T; Ando T; Nakahashi Y; Sakuma M; Miyahara M
    Jpn Circ J; 1979 Mar; 43(3):147-52. PubMed ID: 109645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alterations in sodium and water metabolism on urinary excretion of active and inactive kallikrein in man.
    Lieberthal W; Oza NB; Arbeit L; Bernard DB; Levinsky NG
    J Clin Endocrinol Metab; 1983 Mar; 56(3):513-9. PubMed ID: 6549759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.